Servier Enters Into a Type 2 Diabetes partnership With Canadian Firm Prognomix Inc.
SURESNES, France and MONTRÉAL, November 8, 2011 (ots/PRNewswire) - Les Laboratoires Servier, France (Servier) and Prognomix Inc., Canada (Prognomix) announced today that they have entered into a research and development agreement aimed at identifying novel targets as part of programs meant to develop innovative type 2 diabetes and metabolic disease treatment. This ...
mehr